Strengths
Airgo's innovative non-invasive technology allows for continuous respiratory monitoring, setting it apart from traditional methods.
The platform boasts a high accuracy rate in identifying obstructive sleep apnea, with a 94% positive predictive value, enhancing its clinical credibility.
Strong partnerships with renowned medical institutions, such as Massachusetts General Hospital, bolster Airgo's reputation and reliability in the healthcare sector.
Real-time analytics and predictive alerts provide healthcare professionals with actionable insights, improving patient care and treatment outcomes.
The device's lightweight and miniaturized design (weighing only 75 grams) makes it suitable for a wide range of patients, including those in critical care.
Integration of AI and edge computing enhances data analysis capabilities, allowing for more precise and timely diagnostics.
The platform supports both hospital and home use, catering to diverse patient needs and increasing its market reach.
Airgo's commitment to clinical excellence is demonstrated through extensive trials involving over 1,100 patients and 15,000+ hours of validated data.